Top

Clinical Reviews in Allergy & Immunology

Published in:

01-12-2011

Atopic Dermatitis and the Nervous System

Author: Laurent Misery

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2011

Abstract

Due to the narrow associations between the skin, immune system, and nervous system, nerve endings are very important in the pathophysiology of inflammatory dermatoses and especially in atopic dermatitis. Many neurotransmitters and nerve growth factors that are released in blood or skin are involved in neurogenic inflammation, which dramatically enhance the inflammation induced by immune cells. During times of stress, their release is highly enhanced. In atopic dermatitis lesions, there are many specific changes in skin neurobiology and neurophysiology. These interesting data suggest that novel therapeutic possibilities can be imagined.

Cooper KD (1994) Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 102:128–137PubMed

Chateau Y, Misery L (2004) Connections between nerve endings and epidermal cells: are they synapses? Exp Dermatol 13:2–4PubMed

Langerhans P (1868) Uber die Nerven der menschlichen Haut. Virchows Arch Pathol Anat Physiol 44:325–337

Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A et al (1993) Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363:159–163PubMed

Gaudillere A, Misery L, Souchier C, Claudy A, Schmitt D (1996) Intimate associations between PGP9.5-positive nerve fibres and Langerhans cells. Br J Dermatol 135:343–344PubMed

Hilliges M, Wang L, Johansson O (1995) Ultrastructural evidence for nerve fibers within all vital layers of the human epidermis. J Invest Dermatol 104:134–137PubMed

Wiesner-Menzel L, Schulz B, Vakilzadeh F, Czarnetzki BM (1981) Electron microscopal evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol 61:465–469PubMed

Sueki H, Telegan B, Murphy GF (1995) Computer-assisted three-dimensional reconstruction of human dermal dendrocytes. J Invest Dermatol 105:704–708PubMed

Lotti T, Hautmann G, Panconesi E (1995) Neuropeptides in skin. J Am Acad Dermatol 33:482–496PubMed

10.

Eedy DJ, Shaw C, Johnston CF, Buchanan KD (1994) The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography. Clin Exp Dermatol 19:463–472PubMed

11.

Boissel JP, Ohly D, Bros M, Gödtel-Armbrust U, Förstermann U, Frank S (2004) The neuronal nitric oxide synthase is upregulated in mouse skin repair and in response to epidermal growth factor in human HaCaT keratinocytes. J Invest Dermatol 123:132–139PubMed

12.

Boulais N, Misery L (2007) Merkel cells. J Am Acad Dermatol 57:147–165PubMed

13.

Misery L (1997) Skin, immunity and the nervous system. Br J Dermatol 137:843–850PubMed

14.

Cocchia D, Michetti F, Donato R (1981) Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin. Nature 294:85–87PubMed

15.

Misery L, Campos L, Sabido O, Kanitakis J, Dezutter-Dambuyant C, Guyotat D et al (1993) S100 protein and neuron-specific enolase on monocytic leukemic CD1+ cells, probable precursors of Langerhans cells. Eur J Haematol 51:132–135PubMed

16.

Hsieh ST, Choi S, Lin WM, Chang YC, McArthur JC, Griffin JW (1996) Epidermal denervation and its effects on keratinocytes and Langerhans cells. J Neurocytol 25:513–524PubMed

17.

Hamzeh H, Gaudillere A, Sabido O, Tchou I, Lambert C, Schmitt D et al (2000) Expression of PGP9.5 on Langerhans’ cells and their precursors. Acta Derm Venereol 80:14–16PubMed

18.

Bhardwaj RS, Luger TA (1994) Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis. Arch Dermatol Res 287:85–90PubMed

19.

Staniek V, Misery L, Peguet-Navarro J, Abello J, Doutremepuich JD, Claudy A et al (1997) Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P. Arch Dermatol Res 289:285–291PubMed

20.

Staniek V, Misery L, Peguet-Navarro J, Sabido O, Cuber JC, Dezutter-Dambuyant C et al (1996) Expression of gastrin-releasing peptide receptor in human skin. Acta Derm Venereol 76:282–286PubMed

21.

Shimizu T, Streilein JW (1994) Influence of alpha-melanocyte-stimulating hormone on induction of contact hypersensitivity and tolerance. J Dermatol Sci 8:187–193PubMed

22.

Misery L (1998) Langerhans cells in the neuro–immuno–cutaneous system. J Neuroimmunol 89:83–87PubMed

23.

Gillardon F, Moll I, Michel S, Benrath J, Weihe E, Zimmerman M (1995) CGRP and nitric oxide are involved in UV radiation-induced immunosuppression. Eur J Pharamacol Environ Toxic 296:395–400

24.

Hosoi J, Torii H, Fox F, Zan Z, Rook AH, Granstein RD (1995) Alteration of cytokine expression by calcitonin gene-related peptide (CGRP). J Invest Dermatol 105:859

25.

Asahina A, Hosoi J, Beissert S, Stratigos A, Granstein RD (1995) Inhibition of the induction of delayed-type and contact hyeprsensitivity by CGRP. J Immunol 154:3056–3061PubMed

26.

Misery L (2000) The neuro–immuno–cutaneous system and ultraviolet radiation. Photodermatol Photoimmunol Photomed 16:78–81PubMed

27.

Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D (1996) Skin–nervous system interactions. J Invest Dermatol 106:198–204PubMed

28.

Lambert RW, Granstein RD (1998) Neuropeptides and Langerhans cells. Exp Dermatol 7:73–80PubMed

29.

Lotti T, Bianchi B, Panconesi E (1999) Neuropeptides and skin disorders. The new frontiers of neuro–endocrine–cutaneous immunology. Int J Dermatol 38:673–675PubMed

30.

Pincelli C, Fantini F, Gianetti A (1993) Neuropeptides and skin inflammation. Dermatology 187:153–158PubMed

31.

Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81–96PubMed

32.

Luger TA, Lotti T (1998) Neuropeptides: role in inflammatory skin diseases. J Eur Acad Dermatol Venereol 10:207–211PubMed

33.

Marconi A, Terracina M, Fila C, Franchi J, Bonte F, Romagnoli G et al (2003) Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol 121:1515–1521PubMed

34.

Pincelli C, Fantini F, Giannetti A (1994) Nerve growth factor and the skin. Int J Dermatol 33:308–312PubMed

35.

Freund V, Kassel O, Frossard N (2001) Le facteur de croissance des nerfs: un nouveau médiateur de l’inflammation ? Rev Fr Allergol Immunol Clin 41:571–578

36.

Buske-Kirschbaum A, Hellhammer D (2003) Endocrine and immune responses to stress in chronic inflammatory skin disorders. Ann NY Acad Sci 992:231–240PubMed

37.

Slominski A, Wortsman J, Tuckey RC, Paus R (2007) Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol 265–266:143–149PubMed

38.

Al’Abadie MSK, Senior HJ, Bleehen SS, Gawkrodger DJ (1994) Neuropeptides and neuronal marker in atopic dermatitis: a quantified immunohistochemical study. Eur J Dermatol 4:394–398

39.

Tobin D, Nabarro G, De La Faille HB, Van Vloten WA, Van Der Putte SC, Schuurman HJ (1992) Increased number of nerve fibers in atopic dermatitis. J Allergy Clin Immunol 90:613–622PubMed

40.

Pincelli C, Fantini F, Massimi P, Girolimoni G, Seidenari S, Giannetti A (1990) Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 122:745–750PubMed

41.

Pincelli C, Fantini FPM, Gianetti A (1990) Neuropeptide Y-like immunoreactivity in Langerhans cells from patients with atopic dermatitis. J Neurosci 51:219–220

42.

Johansson O, Liu PY, Han SW, Lindberger M, Ljungdahl A, Wahl-Gren CF (1995) An immunohistochemical study of neuroactive substances in the skin of atopic dermatitis. Eur J Dermatol 5:516–523

43.

Rupprecht M, Renders U, Koch HU, Hornstein OP (1993) Twenty-four hour secretion of prolactin in patients with atopic eczema and normal controls. Eur J Dermatol 3:495–498

44.

Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M (2002) Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147:71–79PubMed

45.

Umemoto N, Kakurai M, Okazaki H, Kiyosawa T, Demitsu T, Nakagawa H (2003) Serum levels of vasoactive intestinal peptide are elevated in patients with atopic dermatitis. J Dermatol Sci 31:161–164PubMed

46.

Gordon DJ, Ostlere LS, Holden CA (1997) Neuropeptide modulation of Th1 and Thé cytokines in peripheral blood mononuclear leukocytes in atopic dermatitis and non-atopic controls. Br J Dermatol 137:921–927PubMed

47.

Kim KH, Park KC, Chung JH, Choi HR (2003) The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis. J Dermatol Sci 32:115–124PubMed

48.

Antunez C, Torres MJ, Lopez S, Rodriguez-Pena R, Blanca M, Mayorga C et al (2009) Calcitonin gene-related peptide modulates interleukin-13 in circulating cutaneous lymphocyte-associated antigen-positive T cells in patients with atopic dermatitis. Br J Dermatol 161:547–553PubMed

49.

Wessler I, Reinheimer T, Kilbinger H, Bittinger F, Kirkpatrick CJ, Saloga J et al (2003) Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. Life Sci 72:2169–2172PubMed

50.

Kindt F, Wiegand S, Niemeier V, Kupfer J, Loser C, Nilles M et al (2008) Reduced expression of nicotinic alpha subunits 3, 7, 9 and 10 in lesional and nonlesional atopic dermatitis skin but enhanced expression of alpha subunits 3 and 5 in mast cells. Br J Dermatol 159:847–857PubMed

51.

Munoz-Hoyos A, Espin-Quirantes C, Molina-Carballo A, Uberos J, Contreras-Chova F, Narbona-Lopez E et al (2007) Neuroendocrine and circadian aspects (melatonin and beta-endorphin) of atopic dermatitis in the child. Pediatr Allergy Immunol 18:679–686PubMed

52.

Kim TH, Jung JA, Kim GD, Jang AH, Ahn HJ, Park YS et al (2009) Melatonin inhibits the development of 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. J Pineal Res 47:324–329PubMed

53.

Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D (1995) Increased concentration of beta-endorphin in the sera of patients with severe atopic dermatitis. Acta Derm Venereol 75:9–11PubMed

54.

Tominaga M, Ogawa H, Takamori K (2007) Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. J Invest Dermatol 127:2228–2235PubMed

55.

Bigliardi-Qi M, Lipp B, Sumanovski LT, Buechner SA, Bigliardi PL (2005) Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 210:91–99PubMed

56.

Schlessinger J, Miller B, Gilbert RD, Plott RT (2006) An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis. Arch Dermatol 142:1568–1572PubMed

57.

Patel L, Clayton PE, Addison GM, Price DA, David TJ (1995) Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol 132:950–955PubMed

58.

Paul-Eugene N, Kolb JP, Damais C, Abadie A, Mencia-Huerta JM, Braquet P et al (1994) Beta 2-adrenoceptor agonists regulate the IL-4-induced phenotypical changes and IgE-dependent functions in normal human monocytes. J Leukoc Biol 55:313–320PubMed

59.

Niemeier V, Gieler U, Baerwald C, Kupfer J, Schill WB, Happle R (1996) Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with atopic dermatitis. Eur J Dermatol 6:377–380

60.

Potter PC, Van Wyk L, Martin M, Lentes KU, Dowdle EB (1993) Genetic polymorphism of the beta-2 adrenergic receptor in atopic and non-atopic subjects. Clin Exp Allergy 23:874–877PubMed

61.

Schallreuter KU, Wei Y, Pittelkow MR, Swanson NN, Gibbons NC, Wood JM (2007) Structural and functional alterations in the beta2-adrenoceptor are caused by a point mutation in patients with atopic eczema. Exp Dermatol 16:807–813PubMed

62.

Roguedas AM, Audrezet MP, Scotet V, Dupre-Goetghebeur D, Ferec C, Misery L (2006) Intrinsic atopic dermatitis is associated with a beta-2 adrenergic receptor polymorphism. Acta Derm Venereol 86:447–448PubMed

63.

Schallreuter KU, Pittelkow MR, Swanson NN, Beazley WD, Korner C, Ehrke C et al (1997) Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema. Arch Dermatol Res 289:663–666PubMed

64.

Misery L, Roguedas AM (2004) Atopie et stress. Ann Dermatol Vénéréol 131:1008–1011PubMed

65.

Sugiura H, Omoto M, Hirota Y, Danno K, Uehara M (1997) Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 289:125–131PubMed

66.

Dou YC, Hagstromer L, Emtestam L, Johansson O (2006) Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 298:31–37PubMed

67.

Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z (2009) Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 53:48–54PubMed

68.

Takano N, Sakurai T, Ohashi Y, Kurachi M (2007) Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model. Br J Dermatol 156:241–246PubMed

69.

Grewe M, Vogelsang K, Ruzicka T, Stege H, Krutmann J (2000) Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J Invest Dermatol 114:1108–1112PubMed

70.

Ma L, Gao XH, Zhao LP, Di ZH, McHepange UO, Zhang L et al (2009) Brain-derived neurotrophic factor gene polymorphisms and serum levels in Chinese atopic dermatitis patients. J Eur Acad Dermatol Venereol 23:1277–1281PubMed

71.

Tominaga M, Ogawa H, Takamori K (2008) Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. Br J Dermatol 158:842–844PubMed

72.

Yamaguchi J, Nakamura F, Aihara M, Yamashita N, Usui H, Hida T et al (2008) Semaphorin3A alleviates skin lesions and scratching behavior in NC/Nga mice, an atopic dermatitis model. J Invest Dermatol 128:2842–2849PubMed

73.

Tominaga M, Tengara S, Kamo A, Ogawa H, Takamori K (2009) Psoralen-ultraviolet a therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci 55:40–46PubMed

74.

Wahlgren CF, Ekblom A (1996) Two-point discrimation of itch in patients with atopic dermatitis and healthy subjects. Acta Derm Venereol 76:48–51PubMed

75.

Heyer GR, Hortsein OP (1999) Recent studies of cutaneous nociception in atopic and non-atopic subjects. J Dermatol 26:77–86PubMed

76.

Koppert W, Heyer G, Handwerker H (1996) Atopic eczema and histamine-induced sensations. Dermatology 192:227–232PubMed

77.

Mori T, Ishida K, Mukumoto S, Yamada Y, Imokawa G, Kabashima K et al (2010) Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis. Br J Dermatol 162(1):83–90PubMed

78.

Ozawa M, Tsuchiyama K, Gomi R, Kurosaki F, Kawamoto Y, Aiba S (2009) Neuroselective transcutaneous electrical stimulation reveals neuronal sensitization in atopic dermatitis. J Am Acad Dermatol 60:609–614PubMed

79.

Engel-Yeger B, Habib-Mazawi S, Parush S, Rozenman D, Kessel A, Shani-Adir A (2007) The sensory profile of children with atopic dermatitis as determined by the sensory profile questionnaire. J Am Acad Dermatol 57:610–615PubMed

80.

Shani-Adir A, Rozenman D, Kessel A, Engel-Yeger B (2009) The relationship between sensory hypersensitivity and sleep quality of children with atopic dermatitis. Pediatr Dermatol 26:143–149PubMed

81.

Grosshans E, Selig D, Quenneville Y, Gautherie M (1977) Physiopathologie de la blancheur cholinergique retardée dans l’atopie. Ann Dermatol Vénéréol 104:453–457

82.

Eishi K, Lee JB, Bae SJ, Takenaka M, Katayama I (2002) Impaired sweating function in adult atopic dermatitis: results of the quantitative sudomotor axon reflex test. Br J Dermatol 147:683–688PubMed

83.

Cicek D, Kandi B, Berilgen MS, Bulut S, Tekatas A, Dertliogu SB et al (2008) Does autonomic dysfunction play a role in atopic dermatitis? Br J Dermatol 159:834–838PubMed

84.

Boettger MK, Bär KJ, Dohrmann A, Müller H, Mertins L, Brockmeyer NH et al (2009) Increased vagal modulation in atopic dermatitis. J Dermatol Sci 53:55–59PubMed

85.

Misery L (2001) Are biochemical mediators the missing link between psychosomatics and dermatology ? Dermatol Psychosom 2:178–183

86.

Slominski A, Mihm MC (1996) Potential mechanism of skin response to stress. Int J Dermatol 35:849–851PubMed

87.

Walker CD, Bodnar M, Forget MA, Toufexis DJ, Trottier G (1997) Stress et plasticité neuroendocrinienne. Med Sci 13:509–518

88.

Dhabhar FS (1998) Stress-induced enhancement of cell-mediated immunity. Ann NY Acad Sci 840:359–372PubMed

89.

Dhabhar FS (1999) Mac Ewen BS. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA 96:1059–1064PubMed

90.

Harbuz MS, Conde GL, Marti O, Lightman SL, Jessop DS (1997) The hypothalamic–pituitary–adrenal axis in autoimmunity. Ann NY Acad Sci 823:214–224PubMed

91.

Misery L, Rousset H (2001) La pelade est-elle une maladie psychosomatique ? Rev Méd Interne 22:274–279PubMed

92.

Sandberg S, Paton JY, Ahola S, Mac Cann DC, Mac Guinness D, Hillary CR et al (2000) The role of acute and chronic stress in asthma attacks in children. Lancet 356:982–987PubMed

93.

Kodama A, Horikawa T, Suzuki T, Ajiki W, Takashima T, Harada S et al (1999) Effect of stress on atopic dermatitis: investigation in patients after the great Hanshin earthquake. J Allergy Clin Immunol 104:173–176PubMed

94.

Misery L, Thomas L, Jullien D, Cambazard F, Humbert P, Dubertret L et al (2008) Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatology. Eur J Dermatol 18:412–415PubMed

95.

Chida Y, Hamer M, Steptoe A (2008) A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 70:102–116PubMed

96.

Buske-Kirschbaum A, Geiben A, Hellhammer D (2001) Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 70:6–16PubMed

97.

Von Hertzen LC (2002) Maternal stress and T-cell differentiation of the developing immune system: possible implications for the development of asthma and atopy. J Allergy Clin Immunol 109:923–928

98.

Buske-Kirschbaum A, Gierens A, Hollig H, Hellhammer DH (2002) Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 129:161–167PubMed

99.

Saint-Mézard P, Chavagnac C, Bosset S, Ionescu M, Peyron E, Kaiserlian D et al (2003) Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J Immunol 171:4073–4080PubMed

100.

Katayama I, Bae SJ, Hamasaki Y, Igawa K, Miyazaki Y, Yokozeki H et al (2001) Stress response, tachykinin and cutaneous inflammation. J Invest Dermatol Symp Proc 6:81–86

101.

Arndt J, Smith N, Tausk F (2008) Stress and atopic dermatitis. Curr Allergy Asthma Rep 8:312–317PubMed

102.

Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold KR et al (2001) Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 137:53–59PubMed

103.

Pavlovic S, Daniltchenko M, Tobin DJ, Hagen E, Hunt SP, Klapp BF et al (2008) Further exploring the brain–skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 128:434–446PubMed

104.

Drake LA, Fallon JD, Sober A (1994) Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol 31:613–616PubMed

105.

Kawana S, Kato Y, Omi T (2010) Efficacy of a 5-HT_1a receptor agonist in atopic dermatitis. Clin Exp Dermatol 35(8):835–840PubMed

106.

Stander S, Stander H, Seeliger S, Luger TA, Steinhoff M (2007) Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol 156:1020–1026PubMed

107.

Pereira U, Boulais N, Lebonvallet N, Pennec JP, Dorange G, Misery L (2010) Mechanisms of sensory effects of tacrolimus on the skin. Br J Dermatol 163(1):70–77PubMed

108.

Darsow U, Pfab F, Valet V, Huss-Marp J, Behrendt H, Ring J et al. (2010) Pruritus and atopic dermatitis. Clin Rev Allergy Immunol (in press)

109.

Ulven T, Kostenis E (2010) Novel CRTH2 antagonists: a review of patents from 2006 to 2009. Expert Opin Ther Pat 20:1505–1530PubMed

110.

Misery L (2005) Atopic dermatitis and psychism. Ann Dermatol Vénéréol 132(suppl 1):112–115

111.

Chida Y, Steptoe A, Hirakawa N, Sudo N, Kubo C (2007) The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis. Int Arch Allergy Immunol 144:1–9PubMed

Title: Atopic Dermatitis and the Nervous System
Author: Laurent Misery
Publication date: 01-12-2011
Publisher: Humana Press Inc
Published in: Clinical Reviews in Allergy & Immunology / Issue 3/2011
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-010-8225-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

Role of Dendritic Cells in Atopic Dermatitis: An Update

A Modular View of Cytokine Networks in Atopic Dermatitis

Therapeutic Implications of a Barrier-Based Pathogenesis of Atopic Dermatitis

Pruritus and Atopic Dermatitis

Innate Immunity in Atopic Dermatitis

What is Intrinsic Atopic Dermatitis?

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials